{
    "clinical_study": {
        "@rank": "60478", 
        "arm_group": [
            {
                "arm_group_label": "ECT + saline", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Brief pulse ECT with saline as placebo in each session"
            }, 
            {
                "arm_group_label": "ECT + Ketamine", 
                "arm_group_type": "Experimental", 
                "description": "Brief pulse ECT with 0.05 mg/kg ketamine infusion in each session"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether combination of ketamine plus\n      electroconvulsive therapy improves depressive symptoms decreasing cognitive side effects."
        }, 
        "brief_title": "Ketamine Use in Electroconvulsive Therapy", 
        "completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Depression", 
        "condition_browse": {
            "mesh_term": [
                "Depression", 
                "Depressive Disorder"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study will compare the clinical response to brief pulse ECT with infusion of ketamine\n      0.5 mg/kg  versus brief pulse electroconvulsive therapy with infusion of placebo (saline) in\n      major depression. We also will compare levels of cognitive impairment among these groups,\n      compare levels of quality of life among these groups, compare levels of BDNF among these\n      groups. We also  will study if levels of 25-hydroxyvitamin D are associated with cognitive\n      impairment in subjects undergoing ECT."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria\n\n        -  Patients with unipolar and bipolar depression from The Psychiatric Unit  of Hospital de\n        Clinicas de Porto Alegre (diagnosis will be established by the Structured Clinical\n        Interview for DSM-IV Axis I)\n\n        Exclusion criteria:\n\n          -  Patients with dementia\n\n          -  History of addiction / abuse of psychoactive drugs\n\n          -  Other psychiatric diagnoses\n\n          -  Refusal to follow the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "53", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02012335", 
            "org_study_id": "13-0196"
        }, 
        "intervention": {
            "arm_group_label": "ECT + Ketamine", 
            "description": "Brief pulse ECT with 0.05 mg/kg ketamine infusion in each session", 
            "intervention_name": "ECT + Ketamine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Ketamine"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "December 9, 2013", 
        "location": {
            "contact": {
                "email": "thiagofernandovf@yahoo.com.br", 
                "last_name": "Thiago FV Freire, MD"
            }, 
            "contact_backup": {
                "email": "mpafleck@gmail.com", 
                "last_name": "Marcelo PA Fleck, PhD"
            }, 
            "facility": {
                "address": {
                    "city": "Porto Alegre", 
                    "country": "Brazil", 
                    "state": "RS", 
                    "zip": "90035-003"
                }, 
                "name": "Federal University of Rio Grande do Sul / Hospital de Cl\u00ednicas de Porto Alegre (HCPA)"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Ketamine Use in Electroconvulsive Therapy: Clinical, Cognitives and Neurotrophic Outcomes", 
        "overall_contact": {
            "email": "thiagofernandovf@yahoo.com.br", 
            "last_name": "Thiago FV Freire, MD"
        }, 
        "overall_contact_backup": {
            "email": "mpafleck@gmail.com", 
            "last_name": "Marcelo PA Fleck, PhD"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Brazil: Minist\u00e9rio da Sa\u00fade", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Hamilton Depression Scale (HAM-D) 17 change", 
            "safety_issue": "Yes", 
            "time_frame": "Baseline, week 1, week 2, week 3, week 4, and at the end of hospital stay, an expected average of 5 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02012335"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Mini Mental Status Exam change", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline and at the end of hospital stay, an expected average of 5 weeks"
            }, 
            {
                "measure": "Autobiographical Memory Test change", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline and at the end of hospital stay, an expected average of 5 weeks"
            }, 
            {
                "measure": "Rey Auditory Verbal Learning Test change", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline and at the end of hospital stay, an expected average of 5 weeks"
            }, 
            {
                "measure": "WAIS Digit Span change", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline and at the end of hospital stay, an expected average of 5 weeks"
            }, 
            {
                "measure": "FAS verbal fluency change", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline and at the end of hospital stay, an expected average of 5 weeks"
            }, 
            {
                "measure": "Stroop Test change", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline and at the end of hospital stay, an expected average of 5 weeks"
            }, 
            {
                "measure": "Trial Making Test change", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline and at the end of hospital stay, an expected average of 5 weeks"
            }, 
            {
                "measure": "WAIS Vocabulary", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline"
            }, 
            {
                "measure": "Montgomery and Asberg Depression Rating Scale change", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline, week 1, week 2, week 3, week 4, and at the end of hospital stay, an expected average of 5 weeks"
            }, 
            {
                "measure": "Brief Psychiatry Rating Scale change", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline, week 1, week 2, week 3, week 4, and at the end of hospital stay, an expected average of 5 weeks"
            }, 
            {
                "measure": "Clinical Global Impression-Severity change", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline, week 1, week 2, week 3, week 4, and at the end of hospital stay, an expected average of 5 weeks"
            }
        ], 
        "source": "Hospital de Clinicas de Porto Alegre", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hospital de Clinicas de Porto Alegre", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}